Found: 21
Select item for more details and to access through your institution.
Marked effect of liver and kidney function on the pharmacokinetics of selegiline.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 54, doi. 10.1016/j.clpt.2004.09.004
- By:
- Publication type:
- Article
Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 6, p. 648, doi. 10.1016/S0009-9236(98)90055-8
- By:
- Publication type:
- Article
CYP2D6 polymorphism is not crucial for the disposition of selegiline<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 4, p. 402, doi. 10.1016/S0009-9236(98)90071-6
- By:
- Publication type:
- Article
Buccal delivery of an α<sub>2</sub>-adrenergic receptor antagonist, atipamezole, in humans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 58, n. 5, p. 506, doi. 10.1016/0009-9236(95)90170-1
- By:
- Publication type:
- Article
Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 57, n. 6, p. 628, doi. 10.1016/0009-9236(95)90225-2
- By:
- Publication type:
- Article
Pharmacokinetic aspects of l-deprenyl (selegiline) and its metabolites<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1994, v. 56, p. 742, doi. 10.1038/clpt.1994.204
- By:
- Publication type:
- Article
Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine.
- Published in:
- Clinical Pharmacology & Therapeutics, 1992, v. 52, n. 5, p. 537, doi. 10.1038/clpt.1992.182
- By:
- Publication type:
- Article
Continuous subcutaneous insulin infusion and propranolol-induced hypoglycemia in a brittle diabetic patient.
- Published in:
- 1984
- By:
- Publication type:
- Case Study
Effect of the novel anxiolytic drug deramciclane on cytochrome P<sub>450</sub> 2D6 activity as measured by desipramine pharmacokinetics.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 59, n. 12, p. 893, doi. 10.1007/s00228-003-0714-z
- By:
- Publication type:
- Article
Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 10, p. 761, doi. 10.1007/s00228-003-0674-3
- By:
- Publication type:
- Article
Effect of concomitant hormone replacement therapy containing estradiol and levonorgestrel on the pharmacokinetics of selegiline.
- Published in:
- European Journal of Clinical Pharmacology, 2002, v. 58, n. 4, p. 259, doi. 10.1007/s00228-002-0469-y
- By:
- Publication type:
- Article
CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline.
- Published in:
- European Journal of Clinical Pharmacology, 2001, v. 57, n. 2, p. 137, doi. 10.1007/s002280100289
- By:
- Publication type:
- Article
Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole.
- Published in:
- European Journal of Clinical Pharmacology, 2001, v. 57, n. 1, p. 37, doi. 10.1007/s002280100278
- By:
- Publication type:
- Article
Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 1, p. 27, doi. 10.1007/s002809900085
- By:
- Publication type:
- Article
Bioavailability of dexmedetomidine after extravascular doses in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 691, doi. 10.1046/j.1365-2125.2003.01944.x
- By:
- Publication type:
- Article
Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 3, doi. 10.1046/j.1365-2125.1999.00891.x
- By:
- Publication type:
- Article
Inhibition of Platelet Monoamine Oxidase Type B by Selegiline.
- Published in:
- 1997
- By:
- Publication type:
- Other
Desmethylselegiline, a Metabolite of Selegiline, Is an Irreversible Inhibitor of Monoamine Oxidase Type B in Humans.
- Published in:
- 1997
- By:
- Publication type:
- Other
Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects.
- Published in:
- 2004
- By:
- Publication type:
- Report
Pharmacokinetics of Deramciclane, a Novel Anxiolytic Agent, after Intravenous and Oral Administration.
- Published in:
- Drugs in R&D, 2003, v. 4, n. 6, p. 339, doi. 10.2165/00126839-200304060-00002
- By:
- Publication type:
- Article
Propranolol and sotalol metabolism after a drinking party.
- Published in:
- Clinical Pharmacology & Therapeutics, 1981, v. 29, n. 6, p. 705, doi. 10.1038/clpt.1981.99
- By:
- Publication type:
- Article